Pinto Alexis
SEC CIK 1819302 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | CLO | 22.2K | — | $2.37M | 4 | 2021-10-25 | 2022-02-14 |
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
Pinto Alexis made no open-market trades at ZNTL in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-14 | 2022-02-14 | ZNTL | Zentalis Pharmaceuticals, Inc. | Pinto Alexis | CLO | S - Sale | $50.23 | -691 | 22.2K | -3% | -$34.7K |
| D | 2022-02-14 | 2022-02-10 | ZNTL | Zentalis Pharmaceuticals, Inc. | Pinto Alexis | CLO | A - Grant | $0.00 | +16.4K | 22.9K | +251% | $0 |
| DM | 2021-10-27 | 2021-10-25 | ZNTL | Zentalis Pharmaceuticals, Inc. | Pinto Alexis | CLO | S - Sale+OE | $77.73 | -30.0K | 6,826 | -81% | -$2.33M |
| D | 2021-10-27 | 2021-10-25 | ZNTL | Zentalis Pharmaceuticals, Inc. | Pinto Alexis | CLO | M - OptEx | $34.40 | +30.0K | 36.5K | +460% | +$1.03M |
Purchase Sale Sale after option exercise All abbreviations